
    
      The study consists of two substudies. Substudy 1 is a two-period, single ascending dose (SAD)
      and multiple ascending dose (MAD) blinded, randomized, placebo-controlled, non-fasting study.
      Designated groups that participate in Period 1 (SAD) will also participate in Period 2 (MAD).
      Substudy 2 is an open-label, randomized two-period, crossover study to examine the effect of
      food on the pharmacokinetics of ABT 072.
    
  